A good environment where all colleagues and disciplines interacted to affect positive growth and change. - Supervisor Merck Employee Review

3.0
13 Aug 2012
Recommend
CEO approval
Business outlook

Pros

Intelligent people. Positive mindset and interaction between disparate groups and departments. Solid leadership. Driven more by the desire to enhance our developmental drugs than by profit margins.

Cons

The only real con was being bought out by a pharma that did not work in the same manner and most certainly did not understand our business culture.

Explore other reviews about Merck

5.0
30 June 2026
Recommend
CEO approval
Business outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
30 June 2026
Recommend
CEO approval
Business outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All